Novo Nordisk Total Non-Operating Income/Expense 2010-2024 | NVO
Novo Nordisk total non-operating income/expense for the twelve months ending June 30, 2024 was $0.214B, a 155.46% decline year-over-year.
- Novo Nordisk annual total non-operating income/expense for 2023 was $0.305B, a 137.47% decline from 2022.
- Novo Nordisk annual total non-operating income/expense for 2022 was $-0.814B, a 1273.13% decline from 2021.
- Novo Nordisk annual total non-operating income/expense for 2021 was $0.069B, a 145.46% decline from 2020.